Stokes Family Office’s iShares iBonds Dec 2031 Term Corporate ETF IBDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$518K Hold
24,730
0.05% 182
2025
Q4
$523K Hold
24,730
0.05% 187
2025
Q3
$525K Hold
24,730
0.05% 173
2025
Q2
$520K Hold
24,730
0.05% 162
2025
Q1
$513K Hold
24,730
0.06% 157
2024
Q4
$503K Hold
24,730
0.05% 162
2024
Q3
$525K Hold
24,730
0.06% 148
2024
Q2
$502K Buy
24,730
+1,500
+6% +$30.3K 0.06% 151
2024
Q1
$476K Buy
23,230
+2,100
+10% +$42.9K 0.06% 150
2023
Q4
$439K Buy
+21,130
New +$416K 0.06% 150

Other funds holding IBDW

Stokes Family Office's IBDW Position: Q1 2026 in Review

Stokes Family Office held its iShares iBonds Dec 2031 Term Corporate ETF (IBDW) position steady in Q1 2026 at 24,730 shares worth $518K. The position accounts for 0.05% of the portfolio, ranked #182.

Stokes Family Office first reported a position in IBDW in Q4 2023 and has held it in 10 quarters since. The position peaked at $525K in Q3 2025. 288 funds tracked by Wall St. Rank hold IBDW as of Q1 2026.

  • Stokes Family Office held 24,730 shares of iShares iBonds Dec 2031 Term Corporate ETF worth $518K as of Q1 2026.
  • Stokes Family Office left its iShares iBonds Dec 2031 Term Corporate ETF share count unchanged in Q1 2026.
  • iShares iBonds Dec 2031 Term Corporate ETF made up 0.05% of Stokes Family Office's portfolio in Q1 2026, its #182 holding.
  • Stokes Family Office first reported a position in iShares iBonds Dec 2031 Term Corporate ETF in Q4 2023 and has held it in 10 quarters since.
  • Stokes Family Office's iShares iBonds Dec 2031 Term Corporate ETF position peaked at $525K in Q3 2025.
  • 288 funds tracked by Wall St. Rank held iShares iBonds Dec 2031 Term Corporate ETF as of Q1 2026.

Based on Stokes Family Office's 13F filing for Q1 2026, filed 12 May 2026.